- All
- Adolescent
- Children
- Community
- Community Health Workers (CHWs)
- COVID-19
- Curriculum design
- Gender
- Governance
- Health Information Systems (HIS)
- Health Policy and Systems Research (HPSR)
- Health Professions Education
- Health Promotion
- Higher Education
- HIV
- Human Resources for Health (HRH)
- Maternal and Child Health (MCH)
- Mental Health
- Multi-sectoral
- Non-Communicable Diseases (NCDs
- Nutrition
- Pharmaceutical Public Health
- Rural
- Sexual and Reproductive Health
- Urban Health
- Violence
- This project, funded by ICARS (International Centre for Antimicrobial Resistance Solutions) through a grant from Wellcome from February to December 2023, developed guidelines to facilitate Responsive Dialogues to tackle antimicrobial resistance (AMR) in LMIC settings.
- This project seeks to address the twin challenges of developing capacity for training and research in pharmaceutical public health and doctoral education, and contributing to the goal of strengthening health and pharmaceutical systems capable of sustainably addressing key threats to health.
- Despite the important roles Community Health Workers (CHWs) play in monitoring TB and HIV treatment, they have almost no training in adverse drug reactions (ADRs) and little material is available on this topic for this level of health worker. The SPaRCS project worked collaboratively between 2020 and 2023 to develop training materials to address this gap. The materials are open source and aim to increase awareness and facilitate initiatives to increase adverse drug reaction reporting by health care workers, including community health workers.
Support to the Regional Centre of Excellence for Vaccines, Immunisation and Health Supply Management
Technical Support to the implementation of the East African Community RCE-VIHSCM- SOPH’s key focus with ITM has been on strengthening South-based knowledge generation based on ‘embedded country’ health policy and systems research (HPSR) and education.
- SPaRCS is a 3-year project which commenced in April 2020 funded by the European and Developing Countries Clinical Trials Partnership (EDCTP)
